Drug Profile
Phthalascidin
Alternative Names: PT 650Latest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Dioxoles; Phthalimides
- Mechanism of Action Alkylating agents; DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Oct 1999 New profile
- 04 Oct 1999 Preclinical development for Cancer in USA (Unknown route)